Intuitive Surgical, Inc. (0R29.L)
USD 527.02
(-3.15%)
USD 527.02
(-3.15%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 4.72 Billion USD | 12.71% |
| 2022 | 4.19 Billion USD | 6.0% |
| 2021 | 3.95 Billion USD | 38.35% |
| 2020 | 2.86 Billion USD | -8.01% |
| 2019 | 3.11 Billion USD | 19.43% |
| 2018 | 2.6 Billion USD | 18.69% |
| 2017 | 2.19 Billion USD | 16.08% |
| 2016 | 1.89 Billion USD | 19.79% |
| 2015 | 1.57 Billion USD | 11.61% |
| 2014 | 1.41 Billion USD | -11.32% |
| 2013 | 1.59 Billion USD | 1.52% |
| 2012 | 1.57 Billion USD | 23.28% |
| 2011 | 1.27 Billion USD | 23.67% |
| 2010 | 1.03 Billion USD | 37.14% |
| 2009 | 751.05 Million USD | 20.99% |
| 2008 | 620.77 Million USD | 49.84% |
| 2007 | 414.28 Million USD | 67.16% |
| 2006 | 247.83 Million USD | 61.38% |
| 2005 | 153.56 Million USD | 74.53% |
| 2004 | 87.99 Million USD | 99.85% |
| 2003 | 44.02 Million USD | 17.61% |
| 2002 | 37.43 Million USD | 59.62% |
| 2001 | 23.45 Million USD | 75.76% |
| 2000 | 13.34 Million USD | 322.04% |
| 1999 | 3.16 Million USD | 0.0% |
| 1998 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 1.37 Billion USD | 0.09% |
| 2024 Q1 | 1.24 Billion USD | -2.51% |
| 2024 Q2 | 1.37 Billion USD | 10.22% |
| 2023 Q3 | 1.16 Billion USD | -0.4% |
| 2023 Q2 | 1.17 Billion USD | 5.29% |
| 2023 Q1 | 1.11 Billion USD | 0.19% |
| 2023 FY | 4.72 Billion USD | 12.71% |
| 2023 Q4 | 1.27 Billion USD | 9.44% |
| 2022 Q3 | 1.05 Billion USD | 2.81% |
| 2022 Q1 | 1 Billion USD | -4.82% |
| 2022 FY | 4.19 Billion USD | 6.0% |
| 2022 Q4 | 1.11 Billion USD | 5.59% |
| 2022 Q2 | 1.02 Billion USD | 1.35% |
| 2021 FY | 3.95 Billion USD | 38.35% |
| 2021 Q2 | 1.02 Billion USD | 13.42% |
| 2021 Q1 | 902.6 Million USD | 0.76% |
| 2021 Q4 | 1.06 Billion USD | 9.2% |
| 2021 Q3 | 971.4 Million USD | -5.11% |
| 2020 Q3 | 724.3 Million USD | 44.02% |
| 2020 FY | 2.86 Billion USD | -8.01% |
| 2020 Q1 | 738.2 Million USD | -17.61% |
| 2020 Q2 | 502.9 Million USD | -31.87% |
| 2020 Q4 | 895.8 Million USD | 23.68% |
| 2019 FY | 3.11 Billion USD | 19.43% |
| 2019 Q4 | 896 Million USD | 14.05% |
| 2019 Q3 | 785.6 Million USD | 3.5% |
| 2019 Q2 | 759 Million USD | 13.35% |
| 2019 Q1 | 669.6 Million USD | -8.98% |
| 2018 Q2 | 632.3 Million USD | 6.48% |
| 2018 Q4 | 735.7 Million USD | 14.54% |
| 2018 FY | 2.6 Billion USD | 18.69% |
| 2018 Q1 | 593.8 Million USD | -6.24% |
| 2018 Q3 | 642.3 Million USD | 1.58% |
| 2017 Q2 | 527.9 Million USD | 13.26% |
| 2017 Q1 | 466.1 Million USD | -11.59% |
| 2017 FY | 2.19 Billion USD | 16.08% |
| 2017 Q4 | 633.3 Million USD | 11.73% |
| 2017 Q3 | 566.8 Million USD | 7.37% |
| 2016 Q4 | 527.2 Million USD | 8.25% |
| 2016 Q2 | 470.9 Million USD | 16.27% |
| 2016 Q3 | 487 Million USD | 3.42% |
| 2016 FY | 1.89 Billion USD | 19.79% |
| 2016 Q1 | 405 Million USD | -11.73% |
| 2015 Q1 | 336.8 Million USD | -14.39% |
| 2015 Q2 | 386.5 Million USD | 14.76% |
| 2015 Q3 | 395.8 Million USD | 2.41% |
| 2015 FY | 1.57 Billion USD | 11.61% |
| 2015 Q4 | 458.8 Million USD | 15.92% |
| 2014 Q4 | 393.4 Million USD | 9.1% |
| 2014 Q1 | 315.4 Million USD | -20.75% |
| 2014 FY | 1.41 Billion USD | -11.32% |
| 2014 Q2 | 344.4 Million USD | 9.19% |
| 2014 Q3 | 360.6 Million USD | 4.7% |
| 2013 Q4 | 398 Million USD | 11.58% |
| 2013 Q2 | 405.2 Million USD | -6.7% |
| 2013 Q1 | 434.3 Million USD | -0.82% |
| 2013 FY | 1.59 Billion USD | 1.52% |
| 2013 Q3 | 356.7 Million USD | -11.97% |
| 2012 Q1 | 355.9 Million USD | -1.93% |
| 2012 FY | 1.57 Billion USD | 23.28% |
| 2012 Q4 | 437.9 Million USD | 12.25% |
| 2012 Q3 | 390.1 Million USD | 0.96% |
| 2012 Q2 | 386.4 Million USD | 8.57% |
| 2011 Q4 | 362.9 Million USD | 11.49% |
| 2011 Q3 | 325.5 Million USD | 6.16% |
| 2011 FY | 1.27 Billion USD | 23.67% |
| 2011 Q2 | 306.6 Million USD | 9.97% |
| 2011 Q1 | 278.8 Million USD | -1.17% |
| 2010 Q2 | 256.8 Million USD | 6.78% |
| 2010 Q4 | 282.1 Million USD | 12.57% |
| 2010 Q3 | 250.6 Million USD | -2.41% |
| 2010 Q1 | 240.5 Million USD | 3.15% |
| 2010 FY | 1.03 Billion USD | 37.14% |
| 2009 Q1 | 128.7 Million USD | -22.16% |
| 2009 FY | 751.05 Million USD | 20.99% |
| 2009 Q4 | 233.15 Million USD | 17.16% |
| 2009 Q3 | 199 Million USD | 4.64% |
| 2009 Q2 | 190.18 Million USD | 47.77% |
| 2008 Q4 | 165.34 Million USD | -2.5% |
| 2008 FY | 620.77 Million USD | 49.84% |
| 2008 Q3 | 169.57 Million USD | 8.66% |
| 2008 Q2 | 156.05 Million USD | 20.22% |
| 2008 Q1 | 129.8 Million USD | -3.99% |
| 2007 Q3 | 108.47 Million USD | 15.26% |
| 2007 Q2 | 94.1 Million USD | 23.0% |
| 2007 Q1 | 76.5 Million USD | 2.09% |
| 2007 FY | 414.28 Million USD | 67.16% |
| 2007 Q4 | 135.2 Million USD | 24.64% |
| 2006 Q3 | 62.23 Million USD | 5.52% |
| 2006 FY | 247.83 Million USD | 61.38% |
| 2006 Q2 | 58.97 Million USD | 14.12% |
| 2006 Q1 | 51.68 Million USD | 6.42% |
| 2006 Q4 | 74.94 Million USD | 20.43% |
| 2005 Q2 | 35.62 Million USD | 30.68% |
| 2005 Q3 | 42.11 Million USD | 18.22% |
| 2005 Q4 | 48.56 Million USD | 15.3% |
| 2005 Q1 | 27.26 Million USD | -8.53% |
| 2005 FY | 153.56 Million USD | 74.53% |
| 2004 Q4 | 29.8 Million USD | 31.17% |
| 2004 Q1 | 15.83 Million USD | 126.26% |
| 2004 Q2 | 19.62 Million USD | 23.95% |
| 2004 Q3 | 22.72 Million USD | 15.76% |
| 2004 FY | 87.99 Million USD | 99.85% |
| 2003 Q2 | 13.54 Million USD | 29.06% |
| 2003 FY | 44.02 Million USD | 17.61% |
| 2003 Q1 | 10.49 Million USD | -9.77% |
| 2003 Q4 | 6.99 Million USD | -46.1% |
| 2003 Q3 | 12.98 Million USD | -4.14% |
| 2002 Q3 | 8.74 Million USD | -13.98% |
| 2002 Q4 | 11.63 Million USD | 33.09% |
| 2002 Q2 | 10.16 Million USD | 47.23% |
| 2002 Q1 | 6.9 Million USD | 1.99% |
| 2002 FY | 37.43 Million USD | 59.62% |
| 2001 Q4 | 6.76 Million USD | 32.4% |
| 2001 Q2 | 6.06 Million USD | 1.97% |
| 2001 Q1 | 5.94 Million USD | 23.04% |
| 2001 FY | 23.45 Million USD | 75.76% |
| 2001 Q3 | 5.11 Million USD | -15.67% |
| 2000 Q4 | 4.83 Million USD | 7.5% |
| 2000 Q3 | 4.49 Million USD | 55.56% |
| 2000 FY | 13.34 Million USD | 322.04% |
| 2000 Q2 | 2.88 Million USD | 155.21% |
| 2000 Q1 | 1.13 Million USD | 0.0% |
| 1999 FY | 3.16 Million USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Phreesia, Inc. | 201.74 Million USD | -2244.296% |
| Accuray Incorporated | 143.12 Million USD | -3204.547% |
| Align Technology, Inc. | 2.72 Billion USD | -73.868% |
| Elevance Health Inc. | 47.01 Billion USD | 89.939% |
| AxoGen, Inc. | 127.87 Million USD | -3598.563% |
| Boston Scientific Corporation | 9.84 Billion USD | 51.98% |
| CVS Health Corporation | 54.43 Billion USD | 91.311% |
| Cardinal Health, Inc. | 7.41 Billion USD | 36.209% |
| Centene Corporation | 153.99 Billion USD | 96.929% |
| DaVita Inc. | 3.82 Billion USD | -23.795% |
| HCA Healthcare, Inc. | 55.06 Billion USD | 91.411% |
| Hologic, Inc. | 2.23 Billion USD | -111.346% |
| Humana Inc. | 106.44 Billion USD | 95.557% |
| IDEXX Laboratories, Inc. | 2.18 Billion USD | -115.962% |
| Laboratory Corporation of America Holdings | 3.36 Billion USD | -40.554% |
| Masimo Corporation | 1 Billion USD | -371.3% |
| McKesson Corporation | 12.58 Billion USD | 62.417% |
| Patterson Companies, Inc. | 1.38 Billion USD | -242.657% |
| Quest Diagnostics Incorporated | 2.96 Billion USD | -59.726% |
| ResMed Inc. | 2.6 Billion USD | -81.291% |
| Henry Schein, Inc. | 3.65 Billion USD | -29.54% |
| Teladoc Health, Inc. | 1.84 Billion USD | -156.705% |
| Universal Health Services, Inc. | 1.17 Billion USD | -302.38% |
| Veeva Systems Inc. | 1.68 Billion USD | -180.452% |
| Baxter International Inc. | 4.97 Billion USD | 4.935% |
| Becton, Dickinson and Company | 8.82 Billion USD | 46.396% |
| Danaher Corporation | 14.12 Billion USD | 66.526% |
| Stryker Corporation | 13.05 Billion USD | 63.781% |
| Medtronic plc | 21.27 Billion USD | 77.768% |